Archives

RxObserver is pleased to announce a distinguished new addition to its Advisory Board and, as well, bid a reluctant farewell to a bright and engaging gentleman who is entering into public service. Joshua Wright, JD, Ph.D., Professor of Law at the George Mason University School …

According to a new study from the University of Pittsburgh, seniors are wasting hundreds of dollars annually on Medicare Part D prescription drug insurance coverage they don’t need. University researchers collected data in 2009 from 412,000 Part D enrollees. The results showed that only 5.2% …

Singulair is a once-daily medication developed by Merck for the treatment of asthma and allergies. In the last quarter prior to the generic announcement, Singulair sales were $1.43 billion. This past August, the FDA announced that it had granted ten generic drug makers approval to …

A new study in Health Affairs provides additional evidence of how the switch from brand-name to generic drugs has helped to hold down overall health costs. According to the study by Peter J. Cunningham, a senior fellow and director of quantitative research at the Center for …

For patients with atrial fibrillation, a common heart rhythm disorder, the risk of having a stroke is increased five-fold. Over 100,000 strokes per year or 10 to 15% of all strokes in the U.S. are the result of atrial fibrillation. Blood-thinning drugs which help prevent …

Most medications on the market today are chemically synthesized compounds. The approval process for generic versions of these chemical medications has been in place for close to 30 years. Starting in the 1980’s a new class of drugs – biotech drugs  – began appearing on …

People with depression can vary significantly in their response to different drug therapies. For patients who do not respond positively to the initial drug tried, less than one half will respond positively to the next drug. As a result, some patients must cycle through a …

With the Supreme Court’s recent ruling largely upholding the Affordable Care Act, we want to turn our attention to various provisions that could have an adverse impact on affordability. Today’s spotlight issue is the health insurance premium tax contained within the ACA. This issue hasn’t …